An ever-increasing pharmacopoeia for the management of patients with bipolar disorder
- PMID: 11153807
An ever-increasing pharmacopoeia for the management of patients with bipolar disorder
Abstract
Bipolar disorder is a recurrent and relapsing mood disorder characterized by cycles of depression and mania. This article addresses the treatment of patients with bipolar mania, which remains one of the most difficult challenges facing clinicians. Patients require safe and effective therapeutic approaches for acute episodes of mania and depression, as well as chronic prophylaxis against future episodes. Monotherapeutic approaches are rarely effective, and combination approaches are associated with an increased risk of adverse events. Lithium is the only agent currently approved for the treatment of both acute episodes of mania and maintenance therapy; however, it is associated with a relatively poor response rate, high relapse rate, and less-than-optimal side effect profile. Other recent approaches have included several anticonvulsant agents, as well as conventional and atypical antipsychotic agents.
Similar articles
-
Treating bipolar depression.J Fam Pract. 2003 Mar;Suppl:S14-7. J Fam Pract. 2003. PMID: 12676079 Review. No abstract available.
-
Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.Bipolar Disord. 2003 Jun;5(3):203-16. doi: 10.1034/j.1399-5618.2003.00032.x. Bipolar Disord. 2003. PMID: 12780874 Review.
-
The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.Bipolar Disord. 2001 Oct;3(5):215-32. Bipolar Disord. 2001. PMID: 11912568 Review.
-
Newer anticonvulsants in the treatment of bipolar disorder.J Clin Psychiatry. 2004;65 Suppl 10:28-35. J Clin Psychiatry. 2004. PMID: 15242330 Review.
-
Antidepressant properties of anticonvulsant drugs for bipolar disorder.J Clin Psychopharmacol. 2003 Apr;23(2):182-92. doi: 10.1097/00004714-200304000-00011. J Clin Psychopharmacol. 2003. PMID: 12640220 Review.
Cited by
-
Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects.Br J Clin Pharmacol. 2006 Apr;61(4):420-6. doi: 10.1111/j.1365-2125.2006.02598.x. Br J Clin Pharmacol. 2006. PMID: 16542203 Free PMC article. Clinical Trial.
-
Adjunctive topiramate treatment in refractory obese bipolar patients: a descriptive open label study.Eat Weight Disord. 2007 Mar;12(1):48-53. doi: 10.1007/BF03327772. Eat Weight Disord. 2007. PMID: 17384530 Clinical Trial.
-
Bipolar spectrum disorders. New perspectives.Can Fam Physician. 2002 May;48:896-904. Can Fam Physician. 2002. PMID: 12053634 Free PMC article. Review.
-
Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission.J Psychiatry Neurosci. 2004 Nov;29(6):459-66. J Psychiatry Neurosci. 2004. PMID: 15644987 Free PMC article.
-
Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder.Drugs. 2005;65(17):2533-51. doi: 10.2165/00003495-200565170-00008. Drugs. 2005. PMID: 16296876 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical